ADO Long tem, page-18

Looking long term and asking why is Anteo where it is today is a good question.

My answer to this along these lines. Investor expectation from the steps ADO has achieved in the last 12 months were that ADO would have sales by now.

Allowing for a discount risk rate of say 33% the share price should be up around 50c.

Hence why is not there today?
strategic paths taken
Sequential step by step approach to approvals has slowed possible roll out.
Delays with CE approval and Operon transfer due to covid
Ignoring the fact that approval and sales in your home market sends a good message to the world - deferring TGA for other markets
Putting off TGA to have a manufacturing grade ISO13485 rather than doing a two step TGA with Operon product followed by ADO product.
Not approaching shareholder base for core of capital raise and being in the hands of placing to quick profit investors pushing down share price

What has been done to resolve this?
Getting distribution agreements in place with reliable companies who will have tested ADO Eugeni and would not be interested in something that is not a market leader
Extensive testing with 3rd parties
Bringing forward ISO13485 upgrade

What can be done further?
Improved marketing
Clear differentiation of ADO v others
Make sales
get key contracts
Improved stakeholder interaction particularly investors

These last items will go demonstrating ADO is crossing the chasm